Minerva Surgical Inc (UTRS)

NASDAQ
0.21
-0.02(-6.91%)
After Hours
0.22
+0.01(+4.62%)
- Real-time Data
  • Volume:
    137,998
  • Day's Range:
    0.20 - 0.22
  • 52 wk Range:
    0.15 - 4.80

UTRS Overview

Prev. Close
0.23
Day's Range
0.2-0.22
Revenue
50.3M
Open
0.21
52 wk Range
0.15-4.8
EPS
-1.18
Volume
137,998
Market Cap
37.12M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,821,073
P/E Ratio
-0.191
Beta
1.22
1-Year Change
-95.6%
Shares Outstanding
176,680,711
Next Earnings Date
May 10, 2023
What is your sentiment on Minerva Surgical?
or
Market is currently closed. Voting is open during market hours.

Minerva Surgical Inc Company Profile

Minerva Surgical Inc Company Profile

Minerva Surgical, Inc. is a commercial-stage medical technology company, which is focused on developing, manufacturing and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The Company has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of abnormal uterine bleeding (AUB) in most uterine anatomies. Its solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. The Company offers a suite of products for the treatment of structural and non-structural causes of AUB in most uterine anatomies. Its devices are utilized by obstetrician-gynecologists (OB/GYNs) across a variety of medical treatment settings, including hospitals, ambulatory surgical centers (ASCs) and physician offices.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellStrong SellStrong Sell
Technical IndicatorsStrong BuyBuyStrong SellStrong SellSell
SummaryStrong SellNeutralStrong SellStrong SellStrong Sell
  • Company Management should be fired and replaced.
    0
    • Management has put the company in play. The offering of control of company with 80 percent of outstanding stock is so bad for current shareholders as to probably lead many to prefer their chances in a bankruptcy than go along with this robbery by management in cahoots with the buyers. Likely another buyer will emerge at these prices from or with ties to current shareholders.
      0
      • Beaten but not dead. Loading
        0
        • Heavily manipulated down.. due for heavily manipulated uptrend beginning within four weeks.
          0
          • Price targets:Year end over a buck3 1/2 by mid Spring
            1
        • 22 cash v 22 mcap
          0
          • and don't forget firesale price on the four products.
            0
          • محمد
            0
        • This is a stock with a decent company with good prospect going forward, but NO investor interest, so the key players can play with as they wish... it appears now they want the price cheap, but they did not mind it being high when it went public.. so as this is controlled by big guys.. the play is which way they want the stock to go.. by guess is they will accumulate another quarter so before moving stock up on improving reporting from company beginning later in the year.
          0
          • sorry for the typos.. first upbeat quarter is not the one being reported at the end of July to early August but rather the one following.. Q3 reported early November or so.
            0